|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 5/12 |
| (11) | Patento numeris | 3087086 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14824322.3 |
| Europos patento paraiškos padavimo data | 2014-12-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-11-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/071310 |
| Data | 2014-12-18 |
| (87) | Numeris | WO 2015/100144 |
| Data | 2015-07-02 |
| (30) | Numeris | Data | Šalis |
| 201361920427 P | 2013-12-23 | US |
| (72) |
BRINGLEY, Dustin, US
CHAN, Johann, US
FUNG, Peter, US
KEATON, Katie, US
LAPINA, Olga, US
MORRISON, Henry, US
PCION, Dominika, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | CRYSTALLINE FORMS OF A MACROCYCLIC HCV NS3 INHIBITING TRIPEPTIDE |
| CRYSTALLINE FORMS OF A MACROCYCLIC HCV NS3 INHIBITING TRIPEPTIDE |